A VLP vaccine platform comprising the core protein of hepatitis B virus with N-terminal antigen capture
Kaniz Fatema, Joseph S. Snowden, Alexander Watson, Lee Sherry, Neil A. Ranson, Nicola J. Stonehouse, David J. Rowlands
The paper describes a modified nanoparticle vaccine platform, N-VelcroVax, which effectively binds SUMO-tagged antigens and shows potential as a vaccine scaffold.
International Journal of Biological Macromolecules · Feb 15, 2025Peer-reviewedMolecular Biology